Skip to main content

Global Biliary Catheters Market Latest Insights Shared in Detailed Research Report 2019 to 2023

Global Biliary Catheters Market Highlights

It is estimated that the global biliary catheters market is expected to register a CAGR 7% during the forecast period of 2019–2024.

Minimally invasive surgery (MIS) can be less disruptive and traumatic for the human body, making it particularly beneficial in elderly patients who are at an increased risk of surgical complications. According to the Population Reference Bureau, the number of Americans ages over 65 was projected to more than double from 46 million in 2014 to over 98 million by 2060.

Non-invasive procedures are helpful in the diagnosis of diseases in geriatric patients. Increasing geriatric population and preference for minimally invasive procedures has boosted the market growth and is expected to support the market growth forecasted period. The high initial costs and adverse stand is expected to hamper the growth of the market.

The global market has more than 80 companies involved in the manufacturing of the various types of biliary catheters such as biliary balloon catheters, single-lumen biliary catheters, double-lumen biliary catheters, and others. Hence the market is not completely dominated by any one or two players but fairly divided among the top manufacturing companies.

Intended Audience

  • Biliary Drainage Catheters Manufacturers
  • Distributors/Traders/Wholesalers
  • Catheters Subcomponent Manufacturers
  • Raw Material Suppliers
  • Research Consultants
  • Investment Research Firms
  • Industry Association
  • Government institutions
  • Research and Development (R&D) companies
  • Medical research laboratories

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/7837

Regional Analysis

The Americas is expected to hold a major share in the global biliary catheters market can be attributed to the surgeon’s preference for laparoscopy over open surgeries, due to the reduced blood loss, minimal scarring, shorter hospital stays, and rapid recovery times.

Europe is expected to hold the second largest share in the biliary catheters market owing to the

increasing prevalence of chronic diseases. Additionally, according to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with healthcare expenditure of EUR 237 billion. People and healthcare organization in this region are able to afford the high cost of the treatment and devices which has helped in driving the growth of the market. In addition to this, increasing government support and funding for the development and improving technology have fueled the growth of the market.

Asia-Pacific was projected to be the fastest growing region for the global biliary catheters market due to the high adoption of MIS technologies, regulatory requirements regarding patient safety. The Middle East and Africa holds the least share in the market due to fewer initiatives taken by the government.

Segmentation

The global biliary catheters market is segmented on the basis of type, application, and end user.

The biliary catheters market by type is categorized into multi-purpose drainage, multi-purpose drainage sump catheter, biliary drainage catheter, nephrostomy catheter, ureteral stent, and others. Based on application, the global biliary catheters market is segmented into thrombectomy, drainage, occlusion, infusion, aspirating, dialysis, diagnostic, monitoring, stent delivery, and dilatation. On the basis of end user, the market is segmented into clinics, hospital, and others.

Key players

Some of the key players in the global biliary catheters market are Boston Scientific Corporation, Conmed, Cook Medical, Endo-Flex, Rontis Medical, Navilyst Medical, Medi-Globe, Angiodynamics, Medtronic, Abbott Laboratories, C.R. Bard, Inc., Infiniti Medical, Argon Medical, Johnson & Johnson, Merit Medical Endotek, Olympus Corporation, Angio Dynamics, Merit Medical, and others.

Access Report Details @  https://www.marketresearchfuture.com/reports/biliary-catheters-market-7837

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibro

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Regional Analysis, Competitive Landscape Forecast to 2023

Idiopathic Pulmonary Fibrosis Treatment is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. Market Overview The high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment. The Global  Idiopathic Pulmonary Fibrosis Treatment Market  is expected to register a  CAGR of 12.3%  during the forecast period of 2019 to 2025, with a market value of USD 2,237 million in 2018. The global IPF treatment market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in Sept

Chatbots in Healthcare Market Research Report by Top Industry Vendors and Applications Scenario till 2023

Chatbots in Healthcare Market Overview Healthcare chatbots are programs which assist patients with queries. This reduces the burden on the clinical staff and lets them focus on their jobs. Automation of various workflow processes in the healthcare sector is likely to propel the demand for these virtual assistants. The global Chatbots in Healthcare Market is expected to touch USD 316.85 million by 2023 at 21.10% CAGR over the forecast period (2018-2023), as per Market Research Future (MRFR). It stood at USD 100.46 million in 2017. Rise of chronic diseases coupled with lack of medical experts to handle queries are main drivers of the market. For instance, cancer patients used chatbots to gain rapid assistance regarding medication and their adverse effects.  The  Chatbots in Healthcare Market   Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the  major players  such As,  Sensely, Inc. (U.S.), Your.MD (U.K.), Buoy Healt